Cargando…

The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies

BACKGROUND: Altered gut microbiome (GM) composition has been established in Parkinson’s disease (PD). However, few studies have longitudinally investigated the GM in PD, or the impact of device-assisted therapies. OBJECTIVES: To investigate the temporal stability of GM profiles from PD patients on s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lubomski, Michal, Xu, Xiangnan, Holmes, Andrew J., Muller, Samuel, Yang, Jean Y. H., Davis, Ryan L., Sue, Carolyn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152137/ https://www.ncbi.nlm.nih.gov/pubmed/35656540 http://dx.doi.org/10.3389/fnagi.2022.875261

Ejemplares similares

Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
por: Lubomski, Michal, et al.
Publicado: (2022)

Health-Related Quality of Life for Parkinson’s Disease Patients and Their Caregivers
por: Lubomski, Michal, et al.
Publicado: (2021)

NEMoE: a nutrition aware regularized mixture of experts model to identify heterogeneous diet-microbiome-host health interactions
por: Xu, Xiangnan, et al.
Publicado: (2023)

Cognitive Influences in Parkinson's Disease Patients and Their Caregivers: Perspectives From an Australian Cohort
por: Lubomski, Michal, et al.
Publicado: (2021)

Increased Added Sugar Consumption Is Common in Parkinson's Disease
por: Palavra, Natalie C., et al.
Publicado: (2021)

Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
por: Chiang, Han-Lin, et al.
Publicado: (2019)

Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
por: Pavan, Sujith, et al.
Publicado: (2022)

Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment
por: Salim, Safa, et al.
Publicado: (2022)

Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
por: Mehanna, Mohammad, et al.
Publicado: (2023)

Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
por: Wallen, Zachary D., et al.
Publicado: (2022)

Exploring human-genome gut-microbiome interaction in Parkinson’s disease
por: Wallen, Zachary D., et al.
Publicado: (2021)

Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection
por: Hey, Grace, et al.
Publicado: (2023)

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
por: Park, Jin-Sung, et al.
Publicado: (2018)

Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort
por: Kenna, Jade E., et al.
Publicado: (2021)

Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease
por: Caputi, Valentina, et al.
Publicado: (2018)

Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis
por: Plassais, Jonathan, et al.
Publicado: (2021)

Cross-Sectional Study on the Gut Microbiome of Parkinson’s Disease Patients in Central China
por: Mao, Liangwei, et al.
Publicado: (2021)

To the Gut Microbiome and Beyond: The Brain-First or Body-First Hypothesis in Parkinson’s Disease
por: Nuzum, Nathan D., et al.
Publicado: (2022)

The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson’s disease
por: Li, Qing, et al.
Publicado: (2023)

Pesticides and the Microbiome-Gut-Brain Axis: Convergent Pathways in the Pathogenesis of Parkinson’s Disease
por: Kulcsarova, Kristina, et al.
Publicado: (2023)

Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
por: Baldini, Federico, et al.
Publicado: (2020)

A single centre prospective study of three device-assisted therapies for Parkinson’s disease
por: Morales-Briceño, Hugo, et al.
Publicado: (2023)

Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson’s Disease: A Systematic Review
por: Boertien, Jeffrey M., et al.
Publicado: (2019)

Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
por: Romano, Stefano, et al.
Publicado: (2021)

Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson’s Disease
por: Fonseca Cabral, Gleyce, et al.
Publicado: (2021)

Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach
por: Forero-Rodríguez, Lady Johanna, et al.
Publicado: (2021)

Parkinson’s Disease, It Takes Guts: The Correlation between Intestinal Microbiome and Cytokine Network with Neurodegeneration
por: Xiromerisiou, Georgia, et al.
Publicado: (2023)

How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
por: Zhang, Ziyi, et al.
Publicado: (2023)

Exploring the Connection Between the Gut Microbiome and Parkinson’s Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options
por: Chan, Dennis G., et al.
Publicado: (2022)

Gut Microbiome Toxicity: Connecting the Environment and Gut Microbiome-Associated Diseases
por: Tu, Pengcheng, et al.
Publicado: (2020)

Gut Microbiome and Cardiovascular Diseases
por: Yoshida, Naofumi, et al.
Publicado: (2018)

The Gut Microbiome and Cardiovascular Disease
por: Astudillo, Andrea A, et al.
Publicado: (2021)

Assistive Devices for Personal Mobility in Parkinson's Disease: A Systematic Review of the Literature
por: García‐Bustillo, Álvaro, et al.
Publicado: (2022)

Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares
por: Azzouz, Doua F, et al.
Publicado: (2023)

The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder
por: Heintz‐Buschart, Anna, et al.
Publicado: (2017)

Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson’s Disease
por: Singh, Yogesh, et al.
Publicado: (2019)

Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome
por: Li, Xue, et al.
Publicado: (2023)

Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk
por: Ré, Diane B., et al.
Publicado: (2023)

Microbiome, Parkinson’s Disease and Molecular Mimicry
por: Miraglia, Fabiana, et al.
Publicado: (2019)

Microbiome changes: an indicator of Parkinson’s disease?
por: Haikal, Caroline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_149adjtuops6qfvom8miiidfkv